Sara Soto, MD
Obstetrics & Gynecology Physician in Whittier, California.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 44,326 in Obstetrics & Gynecology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Sara Soto, MD reported a CMS MIPS final score of 76.3/100 - below the 83.5 national average - and filed 433 Medicare Part D claims in 2023.
- 76.3/100
- MIPS score · -7 vs avg
- 433
- Part D claims, 2023
- 65%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1073835351 · Obstetrics & Gynecology Physician
NPI-10 · ENUM-MID · TAX-MID · MIPS-BELOW · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1073835351
- ENUM-MID 2010
- TAX-MID 44K Obstetrics &
- MIPS-BELOW 76.3/100
- RX-LIGHT 433
- BOOK-LIGHT 4,943 in California
- PHOTO-FINISH Emily Barrows · ±0.1
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Emily Barrows · …
Emily Barrows
76.2 MIPS pts
- Ashley Carroll ·…
Ashley Carroll
76.2 MIPS pts
- Frances Casey · …
Frances Casey
76.2 MIPS pts
- Soto · this prov…
Soto · this provider
76.3 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Sara Soto, MD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
76 ≥ 17th percentile 17% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Sara Soto, MD sits
This provider among obstetrics & gynecology physician peers
Across the 7,360 obstetrics & gynecology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Sara Soto, MD writes more Part D claims than 91% of them and scores higher on MIPS quality than 15% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one obstetrics & gynecology physician peer from a representative sample of 60; the gold marker is Sara Soto, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Sara Soto, MD practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Sara Soto, MD?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in California
How Obstetrics & Gynecology Physician compares to other specialties among California providers
Obstetrics & Gynecology Physician ranks #37 among California's specialties (0.5% of in-state providers)
Each bar is a specialty's share of the California provider total, by primary NUCC taxonomy. The highlighted bar is Obstetrics & Gynecology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Sara Soto, MD's 2023 MIPS final score plotted against the Obstetrics & Gynecology Physician national average
- MIPS Final Score
- 76.3/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Obstetrics & Gynecology Physician US NPIs
76.3/100 MIPS final score - 7.2 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Obstetrics & Gynecology Physician. Quality dim: 62.7. Cost dim: 59.3.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1073835351 |
|---|---|
| Specialty | Obstetrics & Gynecology Physician |
| Credentials | MD |
| Gender | Female |
| NPI Issued | 02/27/2010 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Sara Soto, MD's current license status, disciplinary history, and board certifications with the Medical Board of California in California before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1073835351 is the unique 10-digit identifier CMS uses to link Soto across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Sara Soto, MD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Sara Soto, MD. Source: openpaymentsdata.cms.gov.
Total received
$25
Largest payer
Astellas Pharma US Inc
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - California MBC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~150K California medical licensees in 2023 - they are NOT specific to Sara Soto, MD. To verify Sara Soto, MD's current license status, search the MBC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MBC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the California disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
35% brand-name claims vs 65% generic, on 433 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 652
- Total Day Supply
- 17,448
- Brand vs Generic
- 35% brand / 65% generic
- Brand Drug Cost
- $61K
- Generic Drug Cost
- $18K
- Antibiotic Claims
- 74
Patient Demographics
- Average Patient Age
- 72.6 years
- Avg HCC Risk Score
- 1.39
- Gender Split
- 100% female / 0% male
- Age Distribution
- <65: 13, 65-74: 73, 75-84: 41, 85+: 18
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Sara Soto, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Myrbetriq
Myrbetriq
72 claims
- Estradiol
Estradiol
67 claims
- Nitrofurantoin Mon…
Nitrofurantoin Mono-Macro
47 claims
- Clobetasol Propion… 22
Clobetasol Propionate
22 claims
- Nystatin-Triamcino… 17
Nystatin-Triamcinolone
17 claims
- Yuvafem 17
Yuvafem
17 claims
- Solifenacin Succin… 15
Solifenacin Succinate
15 claims
- Cephalexin 13
Cephalexin
13 claims
| Drug | Claims |
|---|---|
| Myrbetriq Mirabegron | 72 |
| Estradiol | 67 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 47 |
| Clobetasol Propionate | 22 |
| Nystatin-Triamcinolone Nystatin/Triamcinolone Acet | 17 |
| Yuvafem Estradiol | 17 |
| Solifenacin Succinate | 15 |
| Cephalexin | 13 |
| Medroxyprogesterone Acetate | 13 |
| Fluconazole | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Obstetrics & Gynecology Physician Overview
How Sara Soto, MD fits within the Obstetrics & Gynecology Physician landscape nationally.
Sara Soto, MD's 433 claims are above the specialty average of 179.
Nationwide Obstetrics & Gynecology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Soto, both outside California so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (76.3 here).
Same NPPES enumeration year (2010)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Obstetrics & Gynecology Physician Providers in California
Other clinicians with the same primary specialty enrolled in California, drawn from the same CMS NPPES roster as Soto.
One of 4,943 Obstetrics & Gynecology Physician providers enrolled in California, 5 are shown here.
Compare Obstetrics & Gynecology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Sara Soto, MD's specialty? ▼
How much does Sara Soto, MD prescribe under Medicare Part D? ▼
What is Sara Soto, MD's Medicare quality score? ▼
Where is Sara Soto, MD located? ▼
What is Sara Soto, MD's NPI number? ▼
Does Sara Soto, MD prescribe more brand-name or generic drugs? ▼
How many Obstetrics & Gynecology Physician providers are there in the US? ▼
What drugs does Sara Soto, MD prescribe most often? ▼
Does Sara Soto, MD accept Medicare? ▼
How can I verify Sara Soto, MD's credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.